|
Sign In to gain access to subscriptions and/or personal tools.
|
Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results
M Kaufman
Carolinas Medical Center, ROB #410, PO Box 32861, Charlotte, North Carolina 28232-2861, USA, Michael.Kaufman{at}carolinashealthcare.org
C A Gaydos
Johns Hopkins University, Division of Infectious Diseases, 1159 Ross Bldg., 720 Rutland Ave., Baltimore, Maryland 21205, USA
S Sriram
Department of Neurology, Vanderbilt University Medical Center, Vanderbilt Stallworth Rehab, 2201 Capers Ave., Room 1222, Nashville, Tennessee 37212-3164, USA
J Boman
Department of Virology, University of Umeâ, SE-901 85 Umeâ, Sweden
M L Tondella
Center for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, Georgia 30333, USA
H J Norton
Carolinas Medical Center, ROB #410, PO Box 32861, Charlotte, North Carolina 28232-2861, USA
Cerebrospinal fluid samples from controls and patients with multiple sclerosis (MS) were split and sent to laboratories with different experiences for the detection of Chlamydia pneumoniae by polymerase chain reaction. Vanderbilt investigators identified C. pneumoniae in the majority of patients with MS and uncommonly in controls. Laboratories at Johns Hopkins University, University of Umea3, and the Centers for Disease Control and Prevention did not identify C. pneumoniae in any of the samples. Conflicting reports of C. pneumoniae detection in the same samples from patients with MS highlight the need to exchange detection techniques among laboratories involved in this controversy.
Key Words: Chlamydia pneumoniae multiple sclerosis polymerase chain reaction
Multiple Sclerosis, Vol. 8, No. 4,
289-294 (2002)
DOI: 10.1191/1352458502ms815oa

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Parratt, R. Tavendale, J. O'Riordan, D. Parratt, and R. Swingler
Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis
Multiple Sclerosis,
April 1, 2008;
14(3):
292 - 299.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P G Bagos, G Nikolopoulos, and A Ioannidis
Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis
Multiple Sclerosis,
August 1, 2006;
12(4):
397 - 411.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Alonso, S. S. Jick, H. Jick, and M. A. Hernan
Antibiotic Use and Risk of Multiple Sclerosis
Am. J. Epidemiol.,
June 1, 2006;
163(11):
997 - 1002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Contini, R Cultrera, S Seraceni, M Castellazzi, E Granieri, and E Fainardi
Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis
Multiple Sclerosis,
August 1, 2004;
10(4):
360 - 369.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Munger, G. N. DeLorenze, L. I. Levin, M. V. Rubertone, J. H. Vogelman, C. A. Peck, R. W. Peeling, N. Orentreich, and A. Ascherio
A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts
Neurology,
May 25, 2004;
62(10):
1799 - 1803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S J Furrows, J C Hartley, J Bell, N Silver, N Losseff, S Stevenson, M Chapman, E J Thompson, G L Ridgway, and G Giovannoni
Chlamydophila pneumoniae infection of the central nervous system in patients with multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
January 1, 2004;
75(1):
152 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L M. Grimaldi, A Pincherle, F Martinelli-Boneschi, M Filippi, F Patti, A Reggio, D Franciotta, L Allegra, G Comi, and F Blasi
An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients
Multiple Sclerosis,
October 1, 2003;
9(5):
467 - 471.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sriram, S.-y. Yao, C. Stratton, P. Calabresi, W. Mitchell, H. Ikejima, and Y. Yamamoto
Comparative Study of the Presence of Chlamydia pneumoniae in Cerebrospinal Fluid of Patients with Clinically Definite and Monosymptomatic Multiple Sclerosis
Clin. Vaccine Immunol.,
November 1, 2002;
9(6):
1332 - 1337.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|